{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:40:33Z","timestamp":1791906033851,"version":"4.3.4"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p><jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>S. aureus<\/jats:italic>) is a common and virulent human pathogen causing several serious illnesses including skin abscesses, wound infections, endocarditis, osteomyelitis, pneumonia, and toxic shock syndrome. Antibiotics were first introduced in the 1940s, leading to the belief that bacterial illnesses would be eradicated. However, microorganisms, including <jats:italic>S. aureus<\/jats:italic>, began to develop antibiotic resistance from the increased use and abuse of antibiotics. Antibiotic resistance is now one of the most serious threats to global public health. Bacteria like methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) remain a major problem despite several efforts to find new antibiotics. New treatment approaches are required, with bacteriophage treatment, a non-antibiotic strategy to treat bacterial infections, showing particular promise. The ability of <jats:italic>S. aureus<\/jats:italic> to resist a wide range of antibiotics makes it an ideal candidate for phage therapy studies. Bacteriophages have a relatively restricted range of action, enabling them to target pathogenic bacteria. Their usage, usually in the form of a cocktail of bacteriophages, allows for more focused treatment while also overcoming the emergence of resistance. However, many obstacles remain, particularly in terms of their effects <jats:italic>in vivo<\/jats:italic>, necessitating the development of animal models to assess the bacteriophage efficiency. Here, we provide a review of the animal models, the various clinical case treatments, and clinical trials for <jats:italic>S. aureus<\/jats:italic> phage therapy.<\/jats:p>","DOI":"10.3389\/fcimb.2022.907314","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:47:47Z","timestamp":1655441267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":143,"title":["Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Lucile","family":"Plumet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Ahmad-Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dunyach-Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Kissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Costechareyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Molle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01251","article-title":"Commentary: Phage Therapy of Staphylococcal Chronic Osteomyelitis in Experimental Animal Model","volume":"7","author":"Abedon","year":"2016","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal Delivery Systems: Design Optimization and Current Applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e01870","DOI":"10.1128\/AAC.01870-19","article-title":"Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model","volume":"64","author":"Albac","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/v13010051","article-title":"Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens","volume":"13","author":"AL-Ishaq","year":"2021","journal-title":"Viruses"},{"key":"B5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/archderm.1969.01610290034007","article-title":"Neterton\u2019s Syndrome and Ichthyosis Linearis Circumflexa","volume":"100","author":"Altman","year":"1969","journal-title":"Arch. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e00512","DOI":"10.1128\/IAI.00512-19","article-title":"Identification of Novel Bacteriophages With Therapeutic Potential That Target Enterococcus faecalis","volume":"87","author":"Al-Zubidi","year":"2019","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/23744235.2017.1392039","article-title":"Staphylococcus aureus Bacteraemia and Endocarditis - Epidemiology and Outcome: A Review","volume":"50","author":"Asgeirsson","year":"2018","journal-title":"Infect. Dis. (Lond)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.healun.2019.01.001","article-title":"Novel Bacteriophage Therapy for Treatment of Left Ventricular Assist Device Infection","volume":"38","author":"Aslam","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5001\/omj.2019.37","article-title":"WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain","volume":"34","author":"Asokan","year":"2019","journal-title":"Oman Med. J."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245354","article-title":"Klebsiella Virus UPM2146 Lyses Multiple Drug-Resistant Klebsiella pneumoniae In Vitro and In Vivo","volume":"16","author":"Assafiri","year":"2021","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1534734616661058","article-title":"Treatment Failure and Leg Amputation Among Patients With Foot Osteomyelitis","volume":"15","author":"Barshes","year":"2016","journal-title":"Int. J. Low Extrem. Wounds"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3390\/ijms21103715","article-title":"Animal Models to Translate Phage Therapy to Human Medicine","volume":"21","author":"Brix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human Volunteers Receiving Escherichia Coli Phage T4 Orally: A Safety Test of Phage Therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-2-35","article-title":"Dynamics of Success and Failure in Phage and Antibiotic Therapy in Experimental Infections","volume":"2","author":"Bull","year":"2002","journal-title":"BMC Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41598-018-37636-x","article-title":"Phage Therapy Against Pseudomonas aeruginosa Infections in a Cystic Fibrosis Zebrafish Model","volume":"9","author":"Cafora","year":"2019","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental Phage Therapy Against Staphylococcus aureus in Mice","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrobial. Agents Chemother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage Cocktails and the Future of Phage Therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage Therapy\u2013History From Twort and D\u2019Herelle Through Soviet Experience to Current Approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056022","article-title":"Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) From Diabetic Foot Infections","volume":"8","author":"Chhibber","year":"2013","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02146-16","article-title":"Transfersomal Phage Cocktail Is an Effective Treatment Against Methicillin-Resistant Staphylococcus aureus-Mediated Skin and Soft Tissue Infections","volume":"61","author":"Chhibber","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020206","article-title":"Animal Models in the Evaluation of the Effectiveness of Phage Therapy for Infections Caused by Gram-Negative Bacteria From the ESKAPE Group and the Reliability of Its Use in Humans","volume":"9","author":"Cie\u015blik","year":"2021","journal-title":"Microorganisms"},{"key":"B22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mib.2014.11.009","article-title":"Microbial Pathogenesis and Host Defense in the Nematode C. Elegans","volume":"23","author":"Cohen","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/jfd.12536","article-title":"Characterization of Bacteriophage pAh-1 and Its Protective Effects on Experimental Infection of Aeromonas Hydrophila in Zebrafish (Danio Rerio)","volume":"40","author":"Easwaran","year":"2017","journal-title":"J. Fish Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/ciy947","article-title":"A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-Resistant ESKAPE Organisms in Humans","volume":"69","author":"El Haddad","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1242\/dmm.006684","article-title":"C. Elegans: Model Host and Tool for Antimicrobial Drug Discovery","volume":"4","author":"Ewbank","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1874364101509010167","article-title":"Corneal Infection Therapy With Topical Bacteriophage Administration","volume":"9","author":"Fadlallah","year":"2015","journal-title":"TOOPHTJ"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E666","DOI":"10.3390\/nu11030666","article-title":"PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults","volume":"11","author":"Febvre","year":"2019","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.570572","article-title":"Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients With Relapsing S. aureus Prosthetic Knee Infection","volume":"7","author":"Ferry","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy269","article-title":"Salvage Debridement, Antibiotics and Implant Retention (\u201cDAIR\u201d) With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection","volume":"5","author":"Ferry","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.3390\/antibiotics7040087","article-title":"Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage-A Case Report","volume":"7","author":"Fish","year":"2018","journal-title":"Antibiot. (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12968\/jowc.2016.25.Sup7.S27","article-title":"Bacteriophage Treatment of Intransigent Diabetic Toe Ulcers: A Case Series","volume":"25","author":"Fish","year":"2016","journal-title":"J. Wound Care"},{"key":"B32","first-page":"349","article-title":"Evaluation of Therapeutic Effects and Pharmacokinetics of Antibacterial Chromogenic Agents in a Silkworm Model of Staphylococcus aureus Infection","volume":"4","author":"Fujiyuki","year":"2010","journal-title":"Drug Discovery Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1302\/2058-5241.6.210073","article-title":"A Systematic Review of Phage Therapy Applied to Bone and Joint Infections: An Analysis of Success Rates, Treatment Modalities and Safety","volume":"6","author":"Genevi\u00e8re","year":"2021","journal-title":"EFORT Open Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1302\/0301-620X.103B2.BJJ-2020-0452.R2","article-title":"Bacteriophage Therapy for Bone and Joint Infections","author":"Gibb","year":"2021","journal-title":"Bone Joint J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5694\/mja2.50274","article-title":"Adjunctive Bacteriophage Therapy for Prosthetic Valve Endocarditis Due to Staphylococcus aureus","volume":"211","author":"Gilbey","year":"2019","journal-title":"Med. J. Aust."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03227","article-title":"The Ability of Lytic Staphylococcal Podovirus Vb_SauP_phiAGO1.3 to Coexist in Equilibrium With Its Host Facilitates the Selection of Host Mutants of Attenuated Virulence But Does Not Preclude the Phage Antistaphylococcal Activity in a Nematode Infection Model","volume":"9","author":"Glowacka-Rutkowska","year":"2019","journal-title":"Front. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijmm.2010.08.003","article-title":"Adaptation of Staphylococcus aureus to the Cystic Fibrosis Lung","volume":"300","author":"Goerke","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e00542","DOI":"10.1128\/mSystems.00542-20","article-title":"Phages Versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: A Microbiological and Microbiotic Evaluation","volume":"5","author":"Huon","year":"2020","journal-title":"mSystems"},{"key":"B39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and Tolerability of a Cocktail of Bacteriophages to Treat Burn Wounds Infected by Pseudomonas aeruginosa (PhagoBurn): A Randomised, Controlled, Double-Blind Phase 1\/2 Trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"dmm049159","DOI":"10.1242\/dmm.049159","article-title":"Mycobacteriophage\u2013antibiotic Therapy Promotes Enhanced Clearance of Drug-Resistant Mycobacterium abscessus","volume":"14","author":"Johansen","year":"2021","journal-title":"Dis. Models Mech."},{"key":"B41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mpat.2002.0494","article-title":"Silkworm Larvae as an Animal Model of Bacterial Infection Pathogenic to Humans","volume":"32","author":"Kaito","year":"2002","journal-title":"Microb. Pathog."},{"key":"B42","first-page":"89","article-title":"A Silkworm Model of Pathogenic Bacterial Infection","volume":"1","author":"Kaito","year":"2007","journal-title":"Drug Discov. Ther."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157626","article-title":"In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections","volume":"11","author":"Kaur","year":"2016","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12866-020-01891-8","article-title":"Efficacy of Phage Cocktail AB-SA01 Therapy in Diabetic Mouse Wound Infections Caused by Multidrug-Resistant Staphylococcus aureus","volume":"20","author":"Kifelew","year":"2020","journal-title":"BMC Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of Care","volume":"19","author":"Ki","year":"2008","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0971-5916.178615","article-title":"Phage Therapy of Staphylococcal Chronic Osteomyelitis in Experimental Animal Model","volume":"143","author":"Kishor","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0076-6879(06)22011-1","article-title":"Two-Component Signaling in the Virulence of Staphylococcus aureus: A Silkworm Larvae-Pathogenic Agent Infection Model of Virulence","volume":"422","author":"Kurokawa","year":"2007","journal-title":"Methods Enzymol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of Lytic Activity of Staphylococcal Bacteriophage Sb-1 Against Freshly Isolated Clinical Pathogens: Staphylococcal Bacteriophages Sb-1","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microbial. Biotechnol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/v11010088","article-title":"Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the Diagnosis and Treatment of Foot Infection in Persons With Diabetes (IWGDF 2019 Update)","author":"Lipsky","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11958","article-title":"Antimicrobial Resistance Among Enterobacteriaceae, Staphylococcus aureus, and Pseudomonas Spp. Isolates From Clinical Specimens From a Hospital in Nairobi, Kenya","volume":"9","author":"Lord","year":"2021","journal-title":"PeerJ"},{"key":"B54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus Infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/vim.2013.0128","article-title":"Phage Neutralization by Sera of Patients Receiving Phage Therapy","volume":"27","author":"\u0141usiak-Szelachowska","year":"2014","journal-title":"Viral Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2217\/fmb-2016-0156","article-title":"Antiphage Activity of Sera During Phage Therapy in Relation to Its Outcome","volume":"12","author":"\u0141usiak-Szelachowska","year":"2017","journal-title":"Future Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, Stabilisation and Encapsulation of Bacteriophage for Phage Therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv. Colloid. Interface Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/1040841X.2020.1729695","article-title":"Phage Therapy Efficacy: A Review of the Last 10 Years of Preclinical Studies","volume":"46","author":"Melo","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/sur.2018.135","article-title":"Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus","volume":"20","author":"Morris","year":"2018","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226574","article-title":"Evaluation of Bacteriophage as an Adjunct Therapy for Treatment of Peri-Prosthetic Joint Infection Caused by Staphylococcus aureus","volume":"14","author":"Morris","year":"2019","journal-title":"PloS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"bio045203","DOI":"10.1242\/bio.045203","article-title":"Experimental Model of Peri-Prosthetic Infection of the Knee Caused by Staphylococcus aureus Using Biomaterials Representative of Modern TKA","volume":"8","author":"Morris","year":"2019","journal-title":"Biol. Open"},{"key":"B63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/jvi.14.2.198-202.1974","article-title":"Effect of Protein A on Adsorption of Bacteriophages to Staphylococcus aureus","volume":"14","author":"Nordstr\u00f6m","year":"1974","journal-title":"J. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3855\/jidc.7931","article-title":"Efficacy of Lytic Staphylococcus aureus Bacteriophage Against Multidrug-Resistant Staphylococcus aureus in Mice","volume":"10","author":"Oduor","year":"2016","journal-title":"J. Infect. Dev. Ctries"},{"key":"B65","unstructured":"O\u2019NeillJ.\n          Tackling Drug-Resistant Infections Globally: Final Report and Recommendations2016"},{"key":"B66","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","article-title":"Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus","volume":"145","author":"Ooi","year":"2019","journal-title":"JAMA Otolaryngol.\u2013Head Neck Surg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.3390\/v11010018","article-title":"Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review With a Focus on Osteoarticular Infections","volume":"11","author":"Patey","year":"2018","journal-title":"Viruses"},{"key":"B69","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2165\/00003088-200342040-00002","article-title":"Pharmacokinetic Principles of Bacteriophage Therapy","volume":"42","author":"Payne","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.631794","article-title":"Animal Models of Phage Therapy","volume":"12","author":"Penziner","year":"2021","journal-title":"Front. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.747618","article-title":"Alternative Approaches for the Management of Diabetic Foot Ulcers","volume":"12","author":"Pouget","year":"2021","journal-title":"Front. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1164\/rccm.201812-2372OC","article-title":"Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-Associated Pneumonia","volume":"200","author":"Prazak","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats","volume":"225","author":"Prazak","year":"2022","journal-title":"J. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00513","article-title":"Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections","volume":"10","author":"Principi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is Big Pharma Getting Out of Antibacterial Drug Discovery","volume":"6","author":"Projan","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1465-0691.2004.1006.x","article-title":"Antibacterial Drug Discovery: Is It All Downhill From Here","author":"Projan","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/v13061182","article-title":"Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection With Bacteriophage Therapy","volume":"13","author":"Ramirez-Sanchez","year":"2021","journal-title":"Viruses"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060594","article-title":"Zebrafish: An Attractive Model to Study Staphylococcus aureus Infection and Its Use as a Drug Discovery Tool","volume":"14","author":"Rasheed","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B79","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12968\/jowc.2009.18.6.42801","article-title":"Bacteriophage Therapy of Venous Leg Ulcers in Humans: Results of a Phase I Safety Trial","volume":"18","author":"Rhoads","year":"2009","journal-title":"J. Wound Care"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050232","article-title":"Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery","volume":"9","author":"Rubalskii","year":"2020","journal-title":"Antibiotics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023080","article-title":"Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis","author":"Save","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"B83","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/bjo.85.7.842","article-title":"Bacterial Keratitis: A Prospective Clinical and Microbiological Study","volume":"85","author":"Schaefer","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","article-title":"Osteomyelitis","volume":"31","author":"Schmitt","year":"2017","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004847","article-title":"Battling Phages: How Bacteria Defend Against Viral Attack","volume":"11","author":"Seed","year":"2015","journal-title":"PloS Pathog."},{"key":"B86","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and Predictors of Treatment Failure in Total Hip\/Knee Prosthetic Joint Infections Due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1128\/AAC.01277-13","article-title":"The FDA Reboot of Antibiotic Development","volume":"57","author":"Shlaes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/21691401.2014.883401","article-title":"Vesicular System: Versatile Carrier for Transdermal Delivery of Bioactives","volume":"43","author":"Singh","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1086\/524891","article-title":"The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community From the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.resmic.2010.09.011","article-title":"Bacteriophage Therapy for Staphylococcus aureus Bacteremia in Streptozotocin-Induced Diabetic Mice","volume":"161","author":"Sunagar","year":"2010","journal-title":"Res. Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13568-021-01181-0","article-title":"Phages From Ganges River Curtail In Vitro Biofilms and Planktonic Growth of Drug Resistant Klebsiella pneumoniae in a Zebrafish Infection Model","volume":"11","author":"Sundaramoorthy","year":"2021","journal-title":"AMB Express"},{"key":"B92","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/1574-6968.12220","article-title":"Evaluating Efficacy of Bacteriophage Therapy Against Staphylococcus aureus Infections Using a Silkworm Larval Infection Model","volume":"347","author":"Takemura-Uchiyama","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.micinf.2014.02.011","article-title":"Experimental Phage Therapy Against Lethal Lung-Derived Septicemia Caused by Staphylococcus aureus in Mice","volume":"16","author":"Takemura-Uchiyama","year":"2014","journal-title":"Microbes Infect."},{"key":"B94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tcb.2017.10.002","article-title":"Zebrafish Infection: From Pathogenesis to Cell Biology","volume":"28","author":"Torraca","year":"2018","journal-title":"Trends Cell Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13104-021-05796-1","article-title":"Searching for Synergy: Combining Systemic Daptomycin Treatment With Localised Phage Therapy for the Treatment of Experimental Pneumonia Due to MRSA","volume":"14","author":"Valente","year":"2021","journal-title":"BMC Res. Notes"},{"key":"B96","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and Anti-Inflammatory Responses of Peripheral Blood Mononuclear Cells Induced by Staphylococcus aureus and Pseudomonas aeruginosa Phages","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental Bacteriophage Protection Against Staphylococcus aureus Abscesses in a Rabbit Model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage Therapy in Implant-Related Infections: An Experimental Study","volume":"95","author":"Yilmaz","year":"2013","journal-title":"J. Bone Joint Surg. Am. Vol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00094","article-title":"Phage Therapy in a 16-Year-Old Boy With Netherton Syndrome","volume":"4","author":"Zhvania","year":"2017","journal-title":"Front. Med."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01681","article-title":"Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy","volume":"7","author":"\u017baczek","year":"2016","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.907314\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:47:58Z","timestamp":1655441278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.907314\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":100,"alternative-id":["10.3389\/fcimb.2022.907314"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.907314","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"article-number":"907314"}}